Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor

Peking Union Medical College Hospital · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
naovarian-cancer
ovarian cancer, platinum-sensitive recurrent, maintenance therapy, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 916902
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.